Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Cancers | Free Full-Text | Targeting BRAF and RAS in Colorectal Cancer
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision Oncology | JCO Precision Oncology
Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
![PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/50a4df542bd40adc614a990d8984a44bb22f05b5/3-Figure1-1.png "PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar")
PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
BRAF Mutation in Colorectal Cancer | IntechOpen
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Factors affecting treatment selection in RAS/BRAF wild-type... | Download Scientific Diagram
BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
BRAF Mutation and Its Importance in Colorectal Cancer | IntechOpen
IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
